The maximum tumor growth rate predicts clinical outcomes of patients with small‐cell lung cancer undergoing first‐line chemotherapy plus immune‐checkpoint inhibitor therapy

por Chen, Xiang, Chen, Xueyuan, Liu, Tingting, Zhou, Ting, Chen, Gang, Zhou, Huaqiang, Huang, Yan, Fang, Wenfeng, Yang, Yunpeng, Zhou, Ningning, Chen, Likun, Mo, Silang, Zhang, Li, Zhao, Yuanyuan
Publicado 2023

Retraction Note: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells

por Hou, Xue, Gong, Run, Zhan, Jianhua, Zhou, Ting, Ma, Yuxiang, Zhao, Yuanyuan, Zhang, Yaxiong, Chen, Gang, Zhang, Zhonghan, Ma, Shuxiang, Chen, Xi, Gao, Fangfang, Hong, Shaodong, Luo, Fan, Fang, Wenfeng, Yang, Yunpeng, Huang, Yan, Chen, Likun, Yang, Haoxian, Zhang, Li
Publicado 2023

Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors

por Ma, Yuxiang, Xue, Jinhui, Zhao, Yuanyuan, Zhang, Yang, Huang, Yan, Yang, Yunpeng, Fang, Wenfeng, Guo, Ye, Li, Qun, Ge, Xiaoxiao, Sun, Jie, Zhang, Bangyong, Zhang, Yuhan, Xiao, Jinyuan, Zhang, Li, Zhao, Hongyun
Publicado 2023

Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung can...

por Wang, Yixing, Fu, Sha, Zhang, Xuanye, Du, Wei, Luo, Linfeng, Jiang, Yongluo, Zhou, Yixin, Zhao, Yuanyuan, Yang, Yunpeng, Zhao, Hongyun, Fang, Wenfeng, Huang, Yan, Zhang, Li, Hong, Shaodong
Publicado 2023

Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer

por Zhao, Shen, Zhuang, Wu, Han, Baohui, Song, Zhengbo, Guo, Wei, Luo, Feng, Wu, Lin, Hu, Yi, Wang, Huijuan, Dong, Xiaorong, Jiang, Da, Wang, Mingxia, Miao, Liyun, Wang, Qian, Zhang, Junping, Fu, Zhenming, Huang, Yihua, Xu, Chunwei, Hu, Longyu, Li, Lei, Hu, Rong, Yang, Yang, Li, Mengke, Yang, Xiugao, Zhang, Li, Huang, Yan, Fang, Wenfeng
Publicado 2023

Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy

por He, Li-Na, Li, Haifeng, Du, Wei, Fu, Sha, luo, Linfeng, Chen, Tao, Zhang, Xuanye, Chen, Chen, Jiang, Yongluo, Wang, Yixing, Wang, Yuhong, Yu, Hui, Zhou, Yixin, Lin, Zuan, Zhao, Yuanyuan, Huang, Yan, Zhao, Hongyun, Fang, Wenfeng, Yang, Yunpeng, Zhang, Li, Hong, Shaodong
Publicado 2023

AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II tr...

por Zhao, Yuanyuan, Chen, Gang, Chen, Jianhua, Zhuang, Li, Du, Yingying, Yu, Qitao, Zhuang, Wu, Zhao, Yanqiu, Zhou, Ming, Zhang, Weidong, Zhang, Yu, Wan, Yixin, Li, Wenting, Song, Weifeng, Wang, Zhongmin Maxwell, Li, Baiyong, Xia, Michelle, Yang, Yunpeng, Fang, Wenfeng, Huang, Yan, Zhang, Li
Publicado 2023

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

por He, Li-Na, Chen, Tao, Fu, Sha, Jiang, Yongluo, Zhang, Xuanye, Chen, Chen, Du, Wei, Luo, Linfeng, Li, Anlin, Wang, Yixing, Yu, Hui, Zhou, Yixin, Wang, Yuhong, Yang, Yunpeng, Huang, Yan, Zhao, Hongyun, Fang, Wenfeng, Zhang, Li, Hong, Shaodong
Publicado 2023

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer

por Huang, Dingzhi, Lin, Gen, Chu, Qian, Hu, Yi, Wang, Jun, Wang, Zhijie, Yang, Fan, Zhong, Wenzhao, Zhou, Chengzhi, Zhu, Bo, Ai, Xinghao, Cao, Baoshan, Cao, Yabing, Chen, Mingqiu, Chen, Xiaohui, Chu, Tianqing, Duan, Jianchun, Fan, Yun, Fang, Yong, Feng, Shuitu, Feng, Weineng, Guo, Hui, Han, Chengbo, He, Yong, Hong, Shaodong, Hu, Jie, Huang, Meijuan, Huang, Yan, Jiang, Da, Jiang, Kan, Jiang, Richeng, Jin, Bo, Jin, Shi, Li, Jisheng, Li, Min, Li, Ziming, Li, Chao, Lin, Jie, Liu, Anwen, Liu, Si‐Yang Maggie, Liu, Yutao, Liu, Zhefeng, Liu, Zhe, Liu, Zhenhua, Liu, Zhentian, Liu, Zhigang, Lu, Yuping, Lv, Tangfeng, Ma, Zhiyong, Miao, Qian, Peng, Min, Pu, Xingxiang, Ren, Xiu Bao, Shan, Jianzhen, Shan, Jinlu, Shen, Peng, Shen, Bo, Shi, Meiqi, Song, Yong, Song, Zhengbo, Su, ChunXia, Sun, Jianguo, Tian, Panwen, Wang, Jinliang, Wang, Feng, Wang, Huijuan, Wang, Jialei, Wang, Qian, Wang, Wenxian, Wang, Yan, Wu, Lin, Wu, Fang, Xia, Yang, Xie, Congying, Xie, Conghua, Xin, Tao, Xiong, Jianping, Xu, Haipeng, Xu, Song, Xu, Yiquan, Xu, Bin, Xu, Chunwei, Yan, Xiaolong, Yang, Zhenzhou, Yao, Wenxiu, Yu, Yao, Feng, Ye, Yu, Zongyang, Yu, Yongfeng, Yue, Dongsheng, Zhang, Haibo, Zhang, HongMei, Zhang, Li, Zhang, Longfeng, Zhang, Qiuyu, Zhang, Tongmei, Zhang, Bicheng, Zhao, Jun, Zhao, Mingfang, Zheng, Xiaobin, Zhong, Fengqiao, Zhou, Jin, Zhou, Penghui, Zhu, Zhengfei, Zou, Juntao, Zou, Zihua
Publicado 2023

The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institution

por Zhang, Jianwei, Huang, Yan, Li, Xiaoling, Guo, Ying, Zhao, Yuanyuan, Xue, Cong, Hu, Zhihuang, Zhang, Li, Zhao, Hongyun
Publicado 2012

Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer

por Zhao, Hongyun, Huang, Yan, Xue, Cong, Chen, Yang, Hou, Xue, Guo, Ying, Zhao, Liping, Hu, Zhi huang, Huang, Yujie, Luo, Yongzhang, Zhang, Li
Publicado 2013

Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fl...

por Zhao, Hongyun, Zhao, Yuanyuan, Guo, Ying, Huang, Yan, Lin, Suxia, Xue, Cong, Xu, Fei, Zhang, Yang, Zhao, Liping, Hu, Zhihuang, Zhang, Li
Publicado 2013

Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma

por Zhao, Li-Ping, Xue, Cong, Zhang, Jian-Wei, Hu, Zhi-Huang, Zhao, Yuan-Yuan, Zhang, Jing, Huang, Yan, Zhao, Hong-Yun, Zhang, Li
Publicado 2012

SPARC expression and prognostic value in non-small cell lung cancer

por Huang, Yan, Zhang, Jing, Zhao, Yuan-Yuan, Jiang, Wei, Xue, Cong, Xu, Fei, Zhao, Hong-Yun, Zhang, Yang, Zhao, Li-Ping, Hu, Zhi-Huang, Yao, Zhi-Wen, Liu, Qian-Yong, Zhang, Li
Publicado 2012

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC

por Wu, Xuan, Liang, Wenhua, Hou, Xue, Lin, Zhong, Zhao, Hongyun, Huang, Yan, Fang, Wenfeng, Zhao, Yuanyuan, Wu, Jingxun, Yang, Yunpeng, Xue, Chong, Hu, Zhihuang, Zhang, Jing, Zhang, Jianwei, Ma, Yuxiang, Zhou, Ting, Qin, Tao, Zhang, Li
Publicado 2013

Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations

por Liang, Wenhua, Wu, Xuan, Fang, Wenfeng, Zhao, Yuanyuan, Yang, Yunpeng, Hu, Zhihuang, Xue, Cong, Zhang, Jing, Zhang, Jianwei, Ma, Yuxiang, Zhou, Ting, Yan, Yue, Hou, Xue, Qin, Tao, Dinglin, Xiaoxiao, Tian, Ying, Huang, Peiyu, Huang, Yan, Zhao, Hongyun, Zhang, Li
Publicado 2014

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer

por Zhang, Jian-Wei, Zhao, Yuan-Yuan, Guo, Ying, Xue, Cong, Hu, Zhi-Huang, Huang, Yan, Zhao, Hong-Yun, Zhang, Jing, Wu, Xuan, Fang, Wen-Feng, Ma, Yu-Xiang, Zhang, Li
Publicado 2014

Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients

por Zhao, Hong-Yun, Ma, Guo-Wei, Zou, Ben-Yan, Li, Mei, Lin, Su-Xia, Zhao, Li-Ping, Guo, Ying, Huang, Yan, Tian, Ying, Xie, Dan, Zhang, Li
Publicado 2014

The Good Pain Management (GPM) Ward Program in China and its impact on Chinese cancer patients: the SYSUCC experience

por Yang, Yun-Peng, Ma, Yu-Xiang, Huang, Yan, Zhao, Yuan-Yuan, Xu, Fei, Tian, Ying, Zou, Ben-Yan, Gao, Rui-Zhen, Zhang, Li
Publicado 2014

Multi-Targeted Antiangiogenic Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer: Meta-Analyses of 20 Randomized Controlled Trials and Subgroup Analyses

por Liang, Wenhua, Wu, Xuan, Hong, Shaodong, Zhang, Yaxiong, Kang, Shiyang, Fang, Wenfeng, Qin, Tao, Huang, Yan, Zhao, Hongyun, Zhang, Li
Publicado 2014